Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.7222 | 62 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.92495 | 40 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.03216 | 44 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.30417 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.23845 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.94187 | 37 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.3116 | 51 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.87233 | 65 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.70842 | 62 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.59669 | 60 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.19873 | 68 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.28776 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.51838 | 58 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.83609 | 64 |